 cisplatinum vac end stage squamou cell carcinoma head neck sixteen patient end stage squamou cell carcinoma head neck phase II studi cours cisplatinum vac vincristin weekli interv patient respons cent median surviv time day similar group patient chemotherapi previou trial day